U.S. IMPLANTABLE MEDICAL DEVICES MARKET ANALYSIS

Market News

U.S. Implantable medical devices Market: Key Developments

In February 2022, Abbott, is an U.S. based medical devices and health care company launched the patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational aveir dual-chamber leadless pacemaker represents a significant technological milestone for leadless pacing technology and is the first to occur around the world within the pivotal trial.

In January 2021, Dentsply Sirona, a manufacturer of dental products and technologies, has acquired Datum Dental, a company based in Israel known for its innovative dental regeneration products. The acquisition includes Datum Dental's OSSIX biomaterial portfolio, featuring the clinically superior GLYMATRIX technology. This acquisition aligns with Dentsply Sirona's implant dentistry strategy and strengthens its position in the dental regeneration industry.

In August 28, 2022, Medtronic, a medical device company has announced that its investigational EV ICDSystem achieved a high defibrillation success rate of 98.7% and met safety endpoints in a global clinical trial. The system, designed to treat dangerous heart rhythms, places the lead outside the heart and veins to reduce complications. The results were presented at ESC Congress 2022 and published in The New England Journal of Medicine, showcasing its potential as a safe and effective treatment option. Regulatory approval is pending, and a Continued Access Study is underway.

In November 2022, ZimVie, is a global life sciences leader in the dental and spine markets that develops, launched Next Generation TSX implant in the U.S. These implants are designed for immediate extraction and to offer primary stability to soft and dense bones.